Cargando…
Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur
Acquired hemophilia A (AHA) is a rare hemorrhagic disorder caused by the production of autoantibodies against coagulation factor VIII (FVIII). AHA is associated with significant morbidity and mortality primarily as a result of bleeding. Although many disorders are associated with the development of...
Autores principales: | Miatech, Jennifer L, Kantamani, Deepti, Stagg, M. Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629688/ https://www.ncbi.nlm.nih.gov/pubmed/34868780 http://dx.doi.org/10.7759/cureus.19145 |
Ejemplares similares
-
A Case of “Anaphylaxis” to NovoSeven in a Hemophiliac Patient
por: Wang, Andy, et al.
Publicado: (2023) -
Salivary Duct Carcinoma: Case Reports and Brief Review of the Literature
por: Kantamani, Deepti, et al.
Publicado: (2021) -
Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale
por: Arivazhagan, Sowbharnika, et al.
Publicado: (2021) -
Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))
por: Viuff, D., et al.
Publicado: (2008) -
Use of NovoSeven(® )in cases with massive bleeding following surgery with extracorporeal circulation
por: Dementieva, I, et al.
Publicado: (2004)